Cart
sales@molnova.com
Isonardosinone
CAS No. 27062-01-7
Isonardosinone( —— )
Catalog No. M31931 CAS No. 27062-01-7
Isonardosinone shows potential role in the treatment of neuroinflammation conditions, it inhibits NF- oB- and MAPK-mediated inflammatory pathways.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 459 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIsonardosinone
-
NoteResearch use only, not for human use.
-
Brief DescriptionIsonardosinone shows potential role in the treatment of neuroinflammation conditions, it inhibits NF- oB- and MAPK-mediated inflammatory pathways.
-
DescriptionIsonardosinone shows potential role in the treatment of neuroinflammation conditions, it inhibits NF- oB- and MAPK-mediated inflammatory pathways.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number27062-01-7
-
Formula Weight264.3
-
Molecular FormulaC15H20O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
4-Hydroxychalcone
4-Hydroxychalcone attenuates hyperaldosteronism, inflammation, and renal injury in cryptochrome-null mice.
-
C-Reactive Protein (...
CRP, an acute phase serum protein synthesized in response to inflammatory cytokines, produces antitumor effects in animals. The fragment CRP (174-185) (RS-83277) shows similar activity by significantly enhancing the tumoricidal activity of human monocytes and alveolar macrophages in vitro.
-
6-Prenylapigenin
6-Prenylapigenin is a biologically active flavonoid with anti-tumor activity and antiangiogenic properties. 6-Prenylapigenin exerts cytotoxicity against cancer cells, such as leukemia and solid cancer cells.
